James Field

CEO @ LabGenius Therapeutics 🧬+🤖=💊

📍 United Kingdom🔄 Updated September 2026💼 3 investments📅 7 years investing🗓 Last invested Dec 2020
VC🌍 United Kingdom
3
Total investments
0
Early stage
0
Mid stage
0
Late stage
7y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Dec 2020
Based in London, Hoxton Farms is creating a deliciously fatty future. We craft cruelty-free, sustainable fats to combine with plant protein for delicious meat alternatives.
Angel Investor
Nov 2019
Phytoform are making agriculture sustainable & unlocking the genetic potential of plants.
Angel Investor
Oct 2019
Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/
Experience · 5 entries
All (5)
Investments (3)
Founder (1)
2020
Angel Investor
Dec 2020
Based in London, Hoxton Farms is creating a deliciously fatty future. We craft cruelty-free, sustainable fats to combine with plant protein for delicious meat alternatives.
2019
Angel Investor
Nov 2019
Phytoform are making agriculture sustainable & unlocking the genetic potential of plants.
Angel Investor
Oct 2019
Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/
2012
CEO & Founder
Aug 2012
LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The companys novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.
2008
Summer Intern
Jul 2008
Zouk Capital is a fund manager focused on the opportunities emerging at the intersection of infrastructure, technology and sustainability. Our Infrastructure track focuses on investing in, building, and scaling projects and companies in environmental infrastructure and renewable energy. Focus areas include electric vehicle charging infrastructure, waste-to-energy, energy efficiency, and distributed small-scale energy, primarily in Europe and the UK. Our Technology track helps commercially proven, technology-enabled companies to accelerate their growth, increase market share, and create value while delivering scalable environmental and social impact in the process. Focus areas include cleantech, mobility solutions, and impact-oriented fintech in Europe, the US, and Africa. Based in London, Zouk manages approximately €1billion.
Investment activity
2019–2020 · 3 investments
2019220201
Recent (last 2 years)Earlier